23Jun
M&A Litigation Continued: Simon v. Taubman and Seller Remedies in the Age of COVID-19
Since the start of the COVID-19 pandemic, several buyers in M&A transactions have sought to avoid closing on a transaction alleging that the seller experienced a material adverse effect (MAE) or breached interim operating covenants between signing and closing. A MAE is typically defined in the definitive agreement and can be a heavily negotiated point and interim operating covenants have historically been tied to operating in the ordinary course......
By:
White and Williams LLP
Related
We have long encouraged employers and schools to add a basic Trauma/Stop the Bleeding kit and provid...
Read More >
Disrupting the Disruptor: How a Prepared and Proactive Owner Can Mitigate the Effects of Coronavirus...
Read More >
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the ...
Read More >
The U.S. Department of the Treasury issued final regulations late yesterday that significantly expan...
Read More >
In May 2020, the Securities and Exchange Commission approved amendments to the requirements for fina...
Read More >
Non-Hispanic Applicants Discouraged from Applying or Not Hired Are Encouraged to File a Claim, Feder...
Read More >